Medifast (MED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Imperial Capital Downgrades Medifast (MED) to In-Line
November 7, 2014 6:45 AM ESTImperial Capital downgraded Medifast (NYSE: MED) from Outperform to In-Line with a price target of $32.00 (from $34.00).
Analyst Mitchell Pinheiro comments, "Our price target is about 3% below the recent share price. Our In-Line rating is based on our lower earnings forecast for 2015 which incorporates more subdued growth in the Take Shape For Life segment, the expectation for a flat... More
